Keyword search

Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).

Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.

Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.

Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.

Description: Cardiovascular health measures of the household population, by sex and age group.

Description:

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.

Description:

Number and rate of new cancer cases by stage at diagnosis from 2011 to the most recent diagnosis year available. Included are colorectal, lung, breast, cervical and prostate cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

This public use microdata file (PUMF) contains data for a wide variety of variables collected from the Canadian COVID-19 Antibody and Health Survey (CCAHS). The CCAHS collected information on the presence of chronic conditions, self-reported COVID-19 status, testing history, risk for infection, health behaviours, vaccination status and intentions to get vaccinated. COVID-19 antibody seroprevalence laboratory data, and select demographic information are also available. Survey data were collected between November 2020 and April 2021, with the vast majority of collection occurring in January and February 2021.

Description:

In collaboration with the Public Health Agency of Canada (PHAC), this table provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary. This table will provide an aggregate summary of the data available in the publication 13-26-0003.

Description:

In collaboration with the Public Health Agency of Canada (PHAC), this table provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary. This table will provide an aggregate summary of the data available in the publication 13-26-0003.

Description:

Number of new cases and age-standardized rates of new cancer cases by stage at diagnosis from 2011 to the most recent diagnosis year available. Included are colorectal, lung, breast, cervical and prostate cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description: This table presents a series of indicators relating to the COVID-19 pandemic, including relating to perceptions of Canadians' mental health, precautions they've taken, their experience of symptoms, and willingness to receive vaccine. Estimates are based on preliminary monthly data from the Canadian Community Health Survey, and are provided for the Canadian population aged 18 and older excluding the territories, by gender, age, region of residence, and other demographic characteristics.

Description:

Chronic conditions among seniors aged 65 and older, Canadian Health Survey on Seniors, by age group and sex, Canada (excluding territories) and provinces. This table uses two-year period estimates from the 2019/2020 pooled data. For annual estimates, see table 13-10-0788.

Description:

Number and proportion of prevalent cancer cases for two-, five-, ten- and twenty-year prevalence durations from January 1st,1994 to the most recent index date available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

Annual percent change and average annual percent change in age-standardized cancer mortality rates since 1984 to the most recent data year. The table includes a selection of commonly diagnosed invasive cancers and causes of death are defined based on the World Health Organization International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1999 and on its tenth revision (ICD-10) from 2000 to the most recent year.

Description:

The number and percentage of persons with disabilities, difficulties or long-term health conditions aged 19 and older who experienced accessibility barriers when interacting with federal sector organizations within the last two years, Canada (excluding territories) and provinces (grouped).

Description:

Using data from the 2021 Survey on Accessibility in Federal Sector Organizations (SAFSO), this infographic provides a snapshot of barriers related to accessibility within federal sector organizations for Canadians with disabilities, difficulties or long-term conditions that limit their daily activities.

Description: Using data from the Survey on Accessibility in Federal Sector Organizations (SAFSO), this American Sign Language video examines the accessibility barriers that persons with difficulties or long-term conditions encountered during their interactions with federally regulated organizations or businesses.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description:

This is a health fact sheet about blood cholesterol levels among Canadians 18 to 79 years of age. The results are based on the combined data from cycle 5 (2016-2017) and cycle 6 (2018-2019) of the Canadian Health Measures Survey.

Description: The shift by Canadians to a more physically distanced life resulted in a dramatic reduction in the transmission of COVID-19. However, there are concerns that health behaviours, including physical activity, have consequently changed in ways that will result in an unintended increase in the risk of chronic diseases such as cardiovascular disease, obesity, diabetes and cancer. This study looks at how many Canadians could develop cardiovascular disease over the next three years because of reduced levels of physical activity during the COVID-19 pandemic.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description: Colorectal cancer screening, along with other health care services, was suspended in Canada in the initial phase of the COVID-19 pandemic response. This pause was deemed necessary to allow health care facilities to establish appropriate infection-control measures to prevent COVID-19 outbreaks and to reserve health system capacity for COVID-19 patients. The current article projects the impact of a three-month suspension of screening for colorectal cancer using a fecal test for average-risk individuals, and compares strategies to minimize the harm from screening interruptions. The projections come from OncoSim, a cancer microsimulation model co-developed by Statistics Canada and the Canadian Partnership Against Cancer.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description: This study aims to measure cancer incidence and mortality rates of Registered First Nations people in Ontario and to look at trends over time, particularly in cancer rates that are targeted by screening programs (cervical, breast, colorectal) or public health interventions (smoking). The federal Indian Register, the Ontario Cancer Registry and the Registered Persons Database were linked to develop a cohort of First Nations people diagnosed with cancer in Ontario.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description: The Canadian Health Measures Survey (CHMS) aims to collect important health information through a household interview and direct physical measures at a mobile examination centre (MEC), sometimes referred to as a mobile clinic.